Biomarkers for predicting postmenopausal coronary heart disease

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Coronary heart disease (CHD) is the main cause of death in post-menopausal women (PMW). Beyond the 'traditional cardiovascular risk factors of CHD, newer biomarkers, reflecting inflammation, endothelial function and oxidative stress, have received growing consideration. We systematically reviewed the literature on the biomarkers for predicting CHD in PMW. C-reactive protein, IL-6 and Lipoprotein (a) have been consistently found to be associated with CHD risk in PMW. However, no evidence supports the existence of a causal and independent link between such biomarkers and CHD in PMW. Also, the new biomarkers only marginally improve cardiovascular risk prediction. Upcoming studies are needed to provide further evidence on the validity of the new biomarkers in PMW and to understand their relationships with hormone therapy, opening new avenues for prevention.

Original languageEnglish
Pages (from-to)485-495
Number of pages11
JournalBiomarkers in Medicine
Volume5
Issue number4
DOIs
Publication statusPublished - Aug 2011

Fingerprint

Biomarkers
Coronary Disease
Lipoprotein(a)
Oxidative stress
C-Reactive Protein
Cause of Death
Interleukin-6
Oxidative Stress
Hormones
Inflammation

Keywords

  • atherosclerosis
  • biomarkers
  • coronary heart disease
  • dyslipidemia
  • hormone therapy
  • inflammation
  • menopause
  • oxidative stress

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical
  • Drug Discovery

Cite this

Biomarkers for predicting postmenopausal coronary heart disease. / Spoletini, Ilaria; Vitale, Cristiana; Rosano, Giuseppe M C.

In: Biomarkers in Medicine, Vol. 5, No. 4, 08.2011, p. 485-495.

Research output: Contribution to journalArticle

@article{a5895583febc4f92a3ab4b3464ba670e,
title = "Biomarkers for predicting postmenopausal coronary heart disease",
abstract = "Coronary heart disease (CHD) is the main cause of death in post-menopausal women (PMW). Beyond the 'traditional cardiovascular risk factors of CHD, newer biomarkers, reflecting inflammation, endothelial function and oxidative stress, have received growing consideration. We systematically reviewed the literature on the biomarkers for predicting CHD in PMW. C-reactive protein, IL-6 and Lipoprotein (a) have been consistently found to be associated with CHD risk in PMW. However, no evidence supports the existence of a causal and independent link between such biomarkers and CHD in PMW. Also, the new biomarkers only marginally improve cardiovascular risk prediction. Upcoming studies are needed to provide further evidence on the validity of the new biomarkers in PMW and to understand their relationships with hormone therapy, opening new avenues for prevention.",
keywords = "atherosclerosis, biomarkers, coronary heart disease, dyslipidemia, hormone therapy, inflammation, menopause, oxidative stress",
author = "Ilaria Spoletini and Cristiana Vitale and Rosano, {Giuseppe M C}",
year = "2011",
month = "8",
doi = "10.2217/bmm.11.51",
language = "English",
volume = "5",
pages = "485--495",
journal = "Biomarkers in Medicine",
issn = "1752-0363",
publisher = "Future Medicine Ltd.",
number = "4",

}

TY - JOUR

T1 - Biomarkers for predicting postmenopausal coronary heart disease

AU - Spoletini, Ilaria

AU - Vitale, Cristiana

AU - Rosano, Giuseppe M C

PY - 2011/8

Y1 - 2011/8

N2 - Coronary heart disease (CHD) is the main cause of death in post-menopausal women (PMW). Beyond the 'traditional cardiovascular risk factors of CHD, newer biomarkers, reflecting inflammation, endothelial function and oxidative stress, have received growing consideration. We systematically reviewed the literature on the biomarkers for predicting CHD in PMW. C-reactive protein, IL-6 and Lipoprotein (a) have been consistently found to be associated with CHD risk in PMW. However, no evidence supports the existence of a causal and independent link between such biomarkers and CHD in PMW. Also, the new biomarkers only marginally improve cardiovascular risk prediction. Upcoming studies are needed to provide further evidence on the validity of the new biomarkers in PMW and to understand their relationships with hormone therapy, opening new avenues for prevention.

AB - Coronary heart disease (CHD) is the main cause of death in post-menopausal women (PMW). Beyond the 'traditional cardiovascular risk factors of CHD, newer biomarkers, reflecting inflammation, endothelial function and oxidative stress, have received growing consideration. We systematically reviewed the literature on the biomarkers for predicting CHD in PMW. C-reactive protein, IL-6 and Lipoprotein (a) have been consistently found to be associated with CHD risk in PMW. However, no evidence supports the existence of a causal and independent link between such biomarkers and CHD in PMW. Also, the new biomarkers only marginally improve cardiovascular risk prediction. Upcoming studies are needed to provide further evidence on the validity of the new biomarkers in PMW and to understand their relationships with hormone therapy, opening new avenues for prevention.

KW - atherosclerosis

KW - biomarkers

KW - coronary heart disease

KW - dyslipidemia

KW - hormone therapy

KW - inflammation

KW - menopause

KW - oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=80052051629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052051629&partnerID=8YFLogxK

U2 - 10.2217/bmm.11.51

DO - 10.2217/bmm.11.51

M3 - Article

C2 - 21861670

AN - SCOPUS:80052051629

VL - 5

SP - 485

EP - 495

JO - Biomarkers in Medicine

JF - Biomarkers in Medicine

SN - 1752-0363

IS - 4

ER -